Foyston, Gordon, & Payne Inc Humana Inc Transaction History

Foyston, Gordon, & Payne Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	SELL	$451.42 - $524.21 $540,349 - $627,479	-1,197 Reduced 8.59%	12,730 $5.83 Million
Q3 2023 Oct 26, 2023	BUY	$424.29 - $501.07 $1.78 Million - $2.11 Million	4,204 Added 43.24%	13,927 $6.78 Million
Q2 2023 Aug 01, 2023	BUY	$443.86 - $535.96 $269,423 - $325,327	607 Added 6.66%	9,723 $4.35 Million
Q1 2023 May 03, 2023	SELL	$476.57 - $513.28 $65,290 - $70,319	-137 Reduced 1.48%	9,116 $4.43 Million
Q4 2022 Feb 09, 2023	BUY	$497.04 - $563.0 $2.12 Million - $2.4 Million	4,267 Added 85.58%	9,253 $4.74 Million
Q3 2022 Nov 04, 2022	BUY	$458.85 - $502.89 $34,413 - $37,716	75 Added 1.53%	4,986 $2.42 Million
Q2 2022 Aug 11, 2022	BUY	$420.04 - $468.33 $71,406 - $79,616	170 Added 3.59%	4,911 $2.3 Million
Q1 2022 Apr 27, 2022	BUY	$363.17 - $465.45 $1.72 Million - $2.21 Million	4,741 New	4,741 $2.06 Million

1,092

108M

5.53M

4.7M

Ticker HUM
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 126,554,000
Market Cap $37.4B
Description
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services t...

Get notified when there are updates to the investment portfolio of Foyston, Gordon, & Payne Inc, based on Form 13F filings with the SEC.

Stay updated on Foyston, Gordon, & Payne Inc with notifications on news.